{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:23:04Z","timestamp":1774048984789,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["T32NS007480"],"award-info":[{"award-number":["T32NS007480"]}]},{"name":"NINDS\/NIH","award":["NS092122"],"award-info":[{"award-number":["NS092122"]}]},{"name":"NIA\/NIH","award":["AG057247"],"award-info":[{"award-number":["AG057247"]}]},{"name":"Norman Fixel Institute for Neurological Diseases"},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54-HD079124"],"award-info":[{"award-number":["U54-HD079124"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["9056"],"award-info":[{"award-number":["9056"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM118331"],"award-info":[{"award-number":["GM118331"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mitochondrial quality control is essential for the long-term survival of postmitotic neurons. The E3 ubiquitin ligase Parkin promotes the degradation of damaged mitochondria via mitophagy and mutations in Parkin are a major cause of early-onset Parkinson\u2019s disease (PD). Surprisingly however, mice deleted for <jats:italic>Parkin<\/jats:italic> alone are rather asymptomatic for PD-related pathology, suggesting that other complementary or redundant mitochondrial quality control pathways may exist in neurons. Mitochondrial damage is often accompanied by the release of toxic proteins such as cytochrome <jats:italic>c<\/jats:italic>. We have reported that once in the cytosol, cytochrome <jats:italic>c<\/jats:italic> is targeted for degradation by the E3 ligase CUL9 in neurons. Here we examined whether CUL9 and Parkin cooperate to promote optimal neuronal survival in vivo. We generated mice deficient for both <jats:italic>Cul9<\/jats:italic> and <jats:italic>Parkin<\/jats:italic> and examined them for PD-related phenotypes. Specifically, we conducted assays to examine behavioural deficits (locomotor, sensory, memory and learning) and loss of dopaminergic neurons in both males and females. Our results show that the loss of <jats:italic>Cul9<\/jats:italic> and <jats:italic>Parkin<\/jats:italic> together did not enhance the effect of <jats:italic>Parkin<\/jats:italic> deficiency alone. These results indicate that while both Parkin and CUL9 participate in mitochondrial quality control, neurons likely have multiple redundant mechanisms to ensure their long-term survival.<\/jats:p>","DOI":"10.1038\/s41598-020-73854-y","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T10:02:37Z","timestamp":1602237757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of a Cul9\u2013Parkin double knockout mouse model for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Emilie","family":"Hollville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Joers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Swahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mal\u00fa G.","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl S.","family":"Moy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohanish","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"73854_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"73854_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"73854_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus, J., Zhu, K., Marras, C., Aarsland, D. & van Hilten, J. J. Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet. Neurol. 17, 559\u2013568 (2018).","journal-title":"Lancet. Neurol."},{"key":"73854_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mds.26077","volume":"30","author":"C Pont-Sunyer","year":"2015","unstructured":"Pont-Sunyer, C. et al. The onset of nonmotor symptoms in Parkinson\u2019s disease (the ONSET PD study). Mov. Disord.\u00a030, 229\u2013237 (2015).","journal-title":"Mov. Disord."},{"key":"73854_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.25445","volume":"28","author":"RB Postuma","year":"2013","unstructured":"Postuma, R. B., Gagnon, J. F., Pelletier, A. & Montplaisir, J. Prodromal autonomic symptoms and signs in Parkinson\u2019s disease and dementia with Lewy bodies. Mov. Disord.\u00a028, 597\u2013604 (2013).","journal-title":"Mov. Disord."},{"key":"73854_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"73854_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuro.2012.01.010","volume":"33","author":"WM Caudle","year":"2012","unstructured":"Caudle, W. M., Guillot, T. S., Lazo, C. R. & Miller, G. W. Industrial toxicants and Parkinson\u2019s disease. Neurotoxicology 33, 178\u2013188 (2012).","journal-title":"Neurotoxicology"},{"key":"73854_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795\u2013803 (2008).","journal-title":"J. Cell Biol."},{"key":"73854_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nature04788","volume":"441","author":"J Park","year":"2006","unstructured":"Park, J. et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157\u20131161 (2006).","journal-title":"Nature"},{"key":"73854_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04779","volume":"441","author":"IE Clark","year":"2006","unstructured":"Clark, I. E. et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with Parkin. Nature 441, 1162\u20131166 (2006).","journal-title":"Nature"},{"key":"73854_CR11","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298 (2010).","journal-title":"PLoS Biol."},{"key":"73854_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1083\/jcb.201008084","volume":"191","author":"SM Jin","year":"2010","unstructured":"Jin, S. M. et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933\u2013942 (2010).","journal-title":"J. Cell Biol."},{"key":"73854_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1073\/pnas.0911187107","volume":"107","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. USA 107, 378\u2013383 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73854_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda, N. et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211\u2013221 (2010).","journal-title":"J. Cell Biol."},{"key":"73854_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309\u2013314 (2015).","journal-title":"Nature"},{"key":"73854_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4161\/auto.6.8.13426","volume":"6","author":"D Narendra","year":"2010","unstructured":"Narendra, D., Kane, L. A., Hauser, D. N., Fearnley, I. M. & Youle, R. J. p62\/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6, 1090\u20131106 (2010).","journal-title":"Autophagy"},{"key":"73854_CR17","doi-asserted-by":"publisher","first-page":"E4439","DOI":"10.1073\/pnas.1405752111","volume":"111","author":"YC Wong","year":"2014","unstructured":"Wong, Y. C. & Holzbaur, E. L. Optineurin is an autophagy receptor for damaged mitochondria in Parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. USA 111, E4439-4448 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73854_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","volume":"60","author":"JM Heo","year":"2015","unstructured":"Heo, J. M., Ordureau, A., Paulo, J. A., Rinehart, J. & Harper, J. W. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7\u201320 (2015).","journal-title":"Mol. Cell"},{"key":"73854_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979\u2013980 (1983).","journal-title":"Science"},{"key":"73854_CR20","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas, W. J., Vyas, I. & Heikkila, R. E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36, 2503\u20132508 (1985).","journal-title":"Life Sci."},{"key":"73854_CR21","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira, A. H. et al. Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1, 1269 (1989).","journal-title":"Lancet"},{"key":"73854_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker, W. D. Jr., Boyson, S. J. & Parks, J. K. Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann. Neurol. 26, 719\u2013723 (1989).","journal-title":"Ann. Neurol."},{"key":"73854_CR23","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino, J. J. et al. Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice. J. Biol. Chem. 279, 18614\u201318622 (2004).","journal-title":"J. Biol. Chem."},{"key":"73854_CR24","doi-asserted-by":"publisher","first-page":"e99898","DOI":"10.1371\/journal.pone.0099898","volume":"9","author":"M Damiano","year":"2014","unstructured":"Damiano, M. et al. Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice. PLoS ONE 9, e99898 (2014).","journal-title":"PLoS ONE"},{"key":"73854_CR25","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1074\/jbc.RA117.000499","volume":"293","author":"N Giguere","year":"2018","unstructured":"Giguere, N. et al. Comparative analysis of Parkinson\u2019s disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons. J. Biol. Chem. 293, 9580\u20139593 (2018).","journal-title":"J. Biol. Chem."},{"key":"73854_CR26","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg, M. S. et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628\u201343635 (2003).","journal-title":"J. Biol. Chem."},{"key":"73854_CR27","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.0409598102","volume":"102","author":"FA Perez","year":"2005","unstructured":"Perez, F. A. & Palmiter, R. D. Parkin-deficient mice are not a robust model of Parkinsonism. Proc. Natl. Acad. Sci. USA 102, 2174\u20132179 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73854_CR28","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","volume":"12","author":"JM Itier","year":"2003","unstructured":"Itier, J. M. et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum. Mol. Genet. 12, 2277\u20132291 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"73854_CR29","doi-asserted-by":"publisher","first-page":"10744","DOI":"10.1073\/pnas.0401297101","volume":"101","author":"R Von Coelln","year":"2004","unstructured":"Von Coelln, R. et al. Loss of locus coeruleus neurons and reduced startle in Parkin null mice. Proc. Natl. Acad. Sci. USA 101, 10744\u201310749 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73854_CR30","doi-asserted-by":"publisher","first-page":"a009324","DOI":"10.1101\/cshperspect.a009324","volume":"2","author":"Y Lee","year":"2012","unstructured":"Lee, Y., Dawson, V. L. & Dawson, T. M. Animal models of Parkinson\u2019s disease: vertebrate genetics. Cold Spring Harbor Perspect. Med. 2, a009324 (2012).","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"73854_CR31","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0609874104","volume":"104","author":"C Perier","year":"2007","unstructured":"Perier, C. et al. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc. Natl. Acad. Sci. 104, 8161\u20138166 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"73854_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pbb.2013.01.017","volume":"104","author":"G Park","year":"2013","unstructured":"Park, G., Park, Y. J., Yang, H. O. & Oh, M. S. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism. Pharmacol. Biochem. Behav. 104, 163\u2013168 (2013).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"73854_CR33","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1111\/febs.14970","volume":"286","author":"E Hollville","year":"2019","unstructured":"Hollville, E., Romero, S. E. & Deshmukh, M. Apoptotic cell death regulation in neurons. FEBS J. 286, 3276\u20133298 (2019).","journal-title":"FEBS J."},{"key":"73854_CR34","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ncb1063","volume":"5","author":"D Boehning","year":"2003","unstructured":"Boehning, D. et al. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat. Cell Biol. 5, 1051\u20131061 (2003).","journal-title":"Nat. Cell Biol."},{"key":"73854_CR35","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/1873-3468.13655","volume":"593","author":"K Gonzalez-Arzola","year":"2019","unstructured":"Gonzalez-Arzola, K. et al. New moonlighting functions of mitochondrial cytochrome c in the cytoplasm and nucleus. FEBS Lett. 593, 3101\u20133119 (2019).","journal-title":"FEBS Lett."},{"key":"73854_CR36","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1111\/febs.14366","volume":"285","author":"PA Egorova","year":"2018","unstructured":"Egorova, P. A. & Bezprozvanny, I. B. Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders. FEBS J. 285, 3547\u20133565 (2018).","journal-title":"FEBS J."},{"key":"73854_CR37","doi-asserted-by":"publisher","first-page":"28849","DOI":"10.1074\/jbc.274.41.28849","volume":"274","author":"M Hashimoto","year":"1999","unstructured":"Hashimoto, M., Takeda, A., Hsu, L. J., Takenouchi, T. & Masliah, E. Role of cytochrome c as a stimulator of \u03b1-synuclein aggregation in Lewy body disease. J. Biol. Chem. 274, 28849\u201328852 (1999).","journal-title":"J. Biol. Chem."},{"key":"73854_CR38","doi-asserted-by":"publisher","first-page":"ra67","DOI":"10.1126\/scisignal.2005309","volume":"7","author":"V Gama","year":"2014","unstructured":"Gama, V. et al. The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells. Sci. Signal. 7, ra67 (2014).","journal-title":"Sci. Signal."},{"key":"73854_CR39","first-page":"323","volume":"83","author":"HC Nguyen","year":"2017","unstructured":"Nguyen, H. C., Wang, W. & Xiong, Y. Cullin-RING E3 ubiquitin ligases: bridges to destruction. Subcell. Biochem. 83, 323\u2013347 (2017).","journal-title":"Sub Cell. Biochem."},{"key":"73854_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.molcel.2014.03.046","volume":"54","author":"Z Li","year":"2014","unstructured":"Li, Z. et al. CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity. Mol. Cell 54, 805\u2013819 (2014).","journal-title":"Mol. Cell"},{"key":"73854_CR41","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1038\/cddis.2013.220","volume":"4","author":"AJ Kole","year":"2013","unstructured":"Kole, A. J., Annis, R. P. & Deshmukh, M. Mature neurons: equipped for survival. Cell Death Dis. 4, e689 (2013).","journal-title":"Cell Death Dis."},{"key":"73854_CR42","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1038\/s41467-018-05722-3","volume":"9","author":"A Di Rita","year":"2018","unstructured":"Di Rita, A. et al. HUWE1 E3 ligase promotes PINK1\/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKKalpha. Nat. Commun. 9, 3755 (2018).","journal-title":"Nat. Commun."},{"key":"73854_CR43","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/cdd.2014.101","volume":"21","author":"A Hamacher-Brady","year":"2014","unstructured":"Hamacher-Brady, A., Choe, S. C., Krijnse-Locker, J. & Brady, N. R. Intramitochondrial recruitment of endolysosomes mediates Smac degradation and constitutes a novel intrinsic apoptosis antagonizing function of XIAP E3 ligase. Cell Death Differ. 21, 1862\u20131876 (2014).","journal-title":"Cell Death Differ."},{"key":"73854_CR44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jnr.23729","volume":"94","author":"M Zhu","year":"2016","unstructured":"Zhu, M. et al. Sensory symptoms in Parkinson\u2019s disease: clinical features, pathophysiology, and treatment. J. Neurosci. Res. 94, 685\u2013692 (2016).","journal-title":"J. Neurosci. Res."},{"key":"73854_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","volume":"40","author":"MS Ekker","year":"2017","unstructured":"Ekker, M. S. et al. Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked. Parkinsonism Relat. Disord. 40, 1\u201310 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"73854_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10072-017-3154-8","volume":"39","author":"C Papagno","year":"2018","unstructured":"Papagno, C. & Trojano, L. Cognitive and behavioral disorders in Parkinson\u2019s disease: an update. I: cognitive impairments. Neurol. Sci.\u00a039, 215\u2013223 (2018).","journal-title":"Neurol. Sci."},{"key":"73854_CR47","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","volume":"26","author":"XR Zhu","year":"2007","unstructured":"Zhu, X. R. et al. Non-motor behavioural impairments in Parkin-deficient mice. Eur. J. Neurosci. 26, 1902\u20131911 (2007).","journal-title":"Eur. J. Neurosci."},{"key":"73854_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nbd.2013.09.009","volume":"62","author":"MR Hennis","year":"2014","unstructured":"Hennis, M. R., Marvin, M. A., Taylor, C. M. 2nd. & Goldberg, M. S. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson\u2019s disease. Neurobiol. Dis. 62, 113\u2013123 (2014).","journal-title":"Neurobiol. Dis."},{"key":"73854_CR49","doi-asserted-by":"publisher","first-page":"e114216","DOI":"10.1371\/journal.pone.0114216","volume":"9","author":"D Rial","year":"2014","unstructured":"Rial, D. et al. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson\u2019s disease. PLoS ONE 9, e114216 (2014).","journal-title":"PLoS ONE"},{"key":"73854_CR50","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1172\/JCI79300","volume":"125","author":"DP Meka","year":"2015","unstructured":"Meka, D. P. et al. Parkin cooperates with GDNF\/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Invest. 125, 1873\u20131885 (2015).","journal-title":"J. Clin. Invest."},{"key":"73854_CR51","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1523\/JNEUROSCI.1384-17.2017","volume":"38","author":"M Pinto","year":"2018","unstructured":"Pinto, M., Nissanka, N. & Moraes, C. T. Lack of parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson\u2019s disease. J. Neurosci. 38, 1042\u20131053 (2018).","journal-title":"J. Neurosci."},{"key":"73854_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin, J. H. et al. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144, 689\u2013702 (2011).","journal-title":"Cell"},{"key":"73854_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yfrne.2017.09.002","volume":"50","author":"JC Jurado-Coronel","year":"2018","unstructured":"Jurado-Coronel, J. C. et al. Sex differences in Parkinson\u2019s disease: features on clinical symptoms, treatment outcome, sexual hormones and genetics. Front. Neuroendocrinol. 50, 18\u201330 (2018).","journal-title":"Front. Neuroendocrinol."},{"key":"73854_CR54","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/hmg\/ddt095","volume":"22","author":"H Matsui","year":"2013","unstructured":"Matsui, H. et al. PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates. Hum. Mol. Genet. 22, 2423\u20132434 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"73854_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nbd.2016.12.024","volume":"100","author":"L Song","year":"2017","unstructured":"Song, L., McMackin, M., Nguyen, A. & Cortopassi, G. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism. Neurobiol. Dis. 100, 30\u201338 (2017).","journal-title":"Neurobiol. Dis."},{"key":"73854_CR56","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.tcb.2018.07.004","volume":"28","author":"E Villa","year":"2018","unstructured":"Villa, E., Marchetti, S. & Ricci, J. E. No Parkin Zone: Mitophagy without Parkin. Trends Cell Biol. 28, 882\u2013895 (2018).","journal-title":"Trends Cell Biol."},{"key":"73854_CR57","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1093\/hmg\/ddw189","volume":"25","author":"R Szargel","year":"2016","unstructured":"Szargel, R. et al. The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway. Hum. Mol. Genet. 25, 3476\u20133490 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"73854_CR58","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.celrep.2017.08.087","volume":"20","author":"E Villa","year":"2017","unstructured":"Villa, E. et al. Parkin-independent mitophagy controls chemotherapeutic response in cancer cells. Cell Rep. 20, 2846\u20132859 (2017).","journal-title":"Cell Rep."},{"key":"73854_CR59","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1073\/pnas.0401081101","volume":"101","author":"E Liani","year":"2004","unstructured":"Liani, E. et al. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 101, 5500\u20135505 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73854_CR60","doi-asserted-by":"publisher","first-page":"947","DOI":"10.15252\/embr.201643147","volume":"18","author":"Z Bhujabal","year":"2017","unstructured":"Bhujabal, Z. et al. FKBP8 recruits LC3A to mediate Parkin-independent mitophagy. EMBO Rep. 18, 947\u2013961 (2017).","journal-title":"EMBO Rep."},{"key":"73854_CR61","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.1038\/srep44373","volume":"7","author":"B Koentjoro","year":"2017","unstructured":"Koentjoro, B., Park, J. S. & Sue, C. M. Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson\u2019s disease. Sci. Rep. 7, 44373 (2017).","journal-title":"Sci. Rep."},{"key":"73854_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb2422","volume":"14","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14, 177\u2013185 (2012).","journal-title":"Nat. Cell Biol."},{"key":"73854_CR63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41598-017-01258-6","volume":"7","author":"VV Rogov","year":"2017","unstructured":"Rogov, V. V. et al. Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins. Sci. Rep. 7, 1131 (2017).","journal-title":"Sci. Rep."},{"key":"73854_CR64","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1074\/jbc.M112.399345","volume":"288","author":"Y Zhu","year":"2013","unstructured":"Zhu, Y. et al. Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J. Biol. Chem. 288, 1099\u20131113 (2013).","journal-title":"J. Biol. Chem."},{"key":"73854_CR65","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neuron.2015.06.034","volume":"87","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. et al. Endogenous Parkin preserves dopaminergic substantia Nigral neurons following mitochondrial DNA mutagenic stress. Neuron 87, 371\u2013381 (2015).","journal-title":"Neuron"},{"key":"73854_CR66","doi-asserted-by":"publisher","first-page":"10825","DOI":"10.1523\/JNEUROSCI.3001-08.2008","volume":"28","author":"TC Frank-Cannon","year":"2008","unstructured":"Frank-Cannon, T. C. et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J. Neurosci.\u00a028, 10825\u201310834 (2008).","journal-title":"J. Neurosci."},{"key":"73854_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.molcel.2014.06.001","volume":"55","author":"E Hollville","year":"2014","unstructured":"Hollville, E., Carroll, R. G., Cullen, S. P. & Martin, S. J. Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin\/PINK1-dependent mitophagy. Mol. Cell 55, 451\u2013466 (2014).","journal-title":"Mol. Cell"},{"key":"73854_CR68","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-10-4300","volume":"71","author":"XH Pei","year":"2011","unstructured":"Pei, X. H. et al. Cytoplasmic CUL9\/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Res. 71, 2969\u20132977 (2011).","journal-title":"Cancer Res."},{"key":"73854_CR69","doi-asserted-by":"publisher","first-page":"ENEURO.0186-18.","DOI":"10.1523\/ENEURO.0186-18.2018","volume":"5","author":"NP Boyer","year":"2018","unstructured":"Boyer, N. P., Monkiewicz, C., Menon, S., Moy, S. S. & Gupton, S. L. Mammalian TRIM67 functions in brain development and behavior. eNeuro5, ENEURO.0186-18.2018 (2018).","journal-title":"eNeuro"},{"key":"73854_CR70","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-140410","volume":"4","author":"CJ Barnum","year":"2014","unstructured":"Barnum, C. J. et al. Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro(R)1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats. J. Parkinson\u2019s Dis. 4, 349\u2013360 (2014).","journal-title":"J. Parkinson's Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73854-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73854-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73854-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:57:52Z","timestamp":1670360272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73854-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73854"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73854-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16886"}}